Related references
Note: Only part of the references are listed.Potentiation of analgesic efficacy but not side effects: Co-administration of an α4β2 neuronal nicotinic acetylcholine receptor agonist and its positive allosteric modulator in experimental models of pain in rats
Chang Z. Zhu et al.
BIOCHEMICAL PHARMACOLOGY (2011)
α4β2 neuronal nicotinic receptor positive allosteric modulation: An approach for improving the therapeutic index of α4β2 nAChR agonists in pain
Chih-Hung Lee et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Unraveling the High- and Low-Sensitivity Agonist Responses of Nicotinic Acetylcholine Receptors
Kasper Harpsoe et al.
JOURNAL OF NEUROSCIENCE (2011)
Guidelines for reporting experiments involving animals: the ARRIVE guidelines
J. C. McGrath et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Carol Kilkenny et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Pharmacological Characterization of the Allosteric Modulator Desformylflustrabromine and Its Interaction with α4β2 Neuronal Nicotinic Acetylcholine Receptor Orthosteric Ligands
Maegan M. Weltzin et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Pharmacological and immunochemical characterization of alpha 2*nicotinic acetylcholine receptors (nAChRs) in mouse brain
Paul Whiteaker et al.
ACTA PHARMACOLOGICA SINICA (2009)
Kinetics of desensitization and recovery from desensitization for human alpha 4 beta 2-nicotinic acetylcholine receptors stably expressed in SH-EP1 cells
Kewei D. Yu et al.
ACTA PHARMACOLOGICA SINICA (2009)
Discovery of 4-(5-(4-Chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a Novel Positive Allosteric Modulator of the α7 Nicotinic Acetylcholine Receptor
Ramin Faghih et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system
Antoine Taly et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
A randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of ABT-594 in patients with diabetic peripheral neuropathic pain
Michael C. Rowbotham et al.
PAIN (2009)
Discovery and optimization of substituted piperidines as potent, selective, CNS-penetrant α4β2 nicotinic acetylcholine receptor potentiators
Brian K. Albrecht et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Synthesis and activity of substituted carbamates as potentiators of the α4β2 nicotinic acetylcholine receptor
Stephanie K. Springer et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
NS11394 [3′-[5-(1-Hydroxy-1-methyl-ethyl)-benzoimidazol-1-yl]-biphenyl-2-carbonitrile], a Unique Subtype-Selective GABAA Receptor Positive Allosteric Modulator: In Vitro Actions, Pharmacokinetic Properties and in Vivo Anxiolytic Efficacy
N. R. Mirza et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
Partial deletion of the nicotinic cholinergic receptor α4 or β2 subunit genes changes the acetylcholine sensitivity of receptor-mediated 86Rb+ efflux in cortex and thalamus and alters relative expression of α4 and β2 subunits
Cecilia Gotti et al.
MOLECULAR PHARMACOLOGY (2008)
Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI) (vol 21, pg 171, 2007)
Geoffrey C. Dunbar
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Synthesis and structure -: Activity relationship studies of 3,6-diazabicyclo[3.2.0]heptanes as novel α4β2 nicotinic acetylcholine receptor selective Agonists
Jianguo Ji et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Prefrontal acetylcholine release controls cue detection on multiple timescales
Vinay Parikh et al.
NEURON (2007)
An allosteric modulator of the α7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo
Daniel B. Timmermann et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Broad-spectrum efficacy across cognitive domains by α7 nicotinic acetylcholine receptor agonism correlates with activation of ERK1/2 and CREB phosphorylation pathways
Robert S. Bitner et al.
JOURNAL OF NEUROSCIENCE (2007)
Nootropic α7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators
Herman J. Ng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Effects of TC-1734 (AZD3480), a selective neuronal nicotinic receptor agonist, on cognitive performance and the EEG of young healthy male volunteers
G. Dunbar et al.
PSYCHOPHARMACOLOGY (2007)
Effect of ispronicline, a neuronal nicotinic acetylcholine receptor partial agonist, in subjects with age associated memory impairment (AAMI)
Geoffrey C. Dunbar et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2007)
Pharmacokinetics and safety profile of ispronicline (TC-1734), a new brain nicotinic receptor partial agonist, in young healthy male volunteers
G. Dunbar et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Cecilia Gotti et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
A novel positive allosteric modulator of the α7 neuronal nicotinic acetylcholine receptor:: In vitro and in vivo characterization
RS Hurst et al.
JOURNAL OF NEUROSCIENCE (2005)
Rat nicotinic acetylcholine receptor alpha 2 beta 2 channels: Comparison of functional properties with alpha 4 beta 2 channels in Xenopus oocytes
SS Khiroug et al.
NEUROSCIENCE (2004)
Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors
ME Nelson et al.
MOLECULAR PHARMACOLOGY (2003)
Localization of nAChR subunit mRNAs in the brain of Macaca mulatta
ZY Han et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
Share Paper
